Spots Global Cancer Trial Database for stage i prostate cancer
Every month we try and update this database with for stage i prostate cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
| Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence | NCT00003645 | Prostate Cancer | Flutamide Leuprolide Acet... | - | M.D. Anderson Cancer Center | |
| Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer | NCT00032006 | Prostate Cancer | brachytherapy radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer | NCT03103321 | Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage I Prostat... PSA Level Five ... PSA Level Less ... PSA Level Ten t... | Internet-Based ... Internet-Based ... Best Practice Quality-of-Life... Questionnaire A... Survey Administ... Laboratory Biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer | NCT00619515 | Prostate Cancer | questionnaire a... implanted fiduc... stereotactic ra... | - 120 Years | Case Comprehensive Cancer Center | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients | NCT01882985 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Docetaxel Lycopene | 21 Years - | University of California, Irvine | |
| Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer | NCT00830635 | Breast Cancer Depression Long-term Effec... Prostate Cancer Psychosocial Ef... | educational int... informational i... internet-based ... questionnaire a... study of socioe... survey administ... psychosocial as... quality-of-life... | - | University of Colorado, Denver | |
| Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery | NCT02144649 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | dietary interve... dietary interve... questionnaire a... Correlative stu... | 21 Years - | Ohio State University Comprehensive Cancer Center | |
| PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 | NCT01672905 | Prostate Cancer | laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | NCT00003858 | Prostate Cancer | mitoxantrone hy... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer | NCT00020995 | Prostate Cancer | therapeutic die... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer | NCT01792024 | Stage I Prostat... Stage II Prosta... | Visualase Therm... magnetic resona... | 45 Years - | University of Chicago | |
| Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | NCT01912820 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | green tea extra... quercetin placebo therapeutic con... laboratory biom... | 40 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | NCT01546987 | Prostate Cancer | GnRH agonist Anti-androgen TAK-700 Radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00020735 | Prostate Cancer | toremifene conventional su... neoadjuvant the... | 18 Years - 120 Years | University of Pittsburgh | |
| Radiation Therapy in Treating Patients With Prostate Cancer | NCT01434290 | Prostate Cancer Psychosocial Ef... Radiation Toxic... Sexual Dysfunct... | 36.25 Gy IMRT 51.6 Gy IMRT | 18 Years - | Radiation Therapy Oncology Group | |
| Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer | NCT03963739 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage III Prost... | Interview Questionnaire A... | 18 Years - | Wake Forest University Health Sciences | |
| Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer | NCT00869739 | Cancer Survivor Depression Gastrointestina... Male Erectile D... Prostate Cancer Psychosocial Ef... Urinary Complic... | telephone-based... educational int... partner-assiste... questionnaire a... psychosocial as... quality-of-life... | - | East Carolina University | |
| Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer | NCT00670046 | Prostate Cancer | valproic acid standard of car... | 18 Years - 85 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | NCT00086736 | Prostate Cancer | bicalutamide eflornithine oral eflornithi... oral bicalutami... | 18 Years - | University of Alabama at Birmingham | |
| Positron Emission Tomography in Prostate Cancer | NCT00121212 | Prostate Cancer | carbon-11 aceta... | - | Washington University School of Medicine | |
| Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | NCT00032058 | Prostate Cancer | magnetic resona... magnetic resona... | 18 Years - | National Cancer Institute (NCI) | |
| Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00402285 | Prostate Cancer | lycopene supple... fish oil supple... Placebo | - | University of California, San Francisco | |
| Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer | NCT00176579 | Osteoporosis Prostate Cancer | dual x-ray abso... | 50 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | NCT00073970 | Prostate Cancer | celecoxib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | NCT00547339 | Prostate Cancer | stereotactic bo... stereotactic bo... stereotactic bo... stereotactic bo... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer | NCT00030277 | Prostate Cancer | high-intensity ... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer | NCT00006101 | Prostate Cancer | eflornithine Placebo | 35 Years - 70 Years | University of California, Irvine | |
| Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate | NCT00030290 | Prostate Cancer | high-intensity ... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Relapsed Prostate Cancer | NCT00482274 | Prostate Cancer | docetaxel | 18 Years - | OHSU Knight Cancer Institute | |
| Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer | NCT00345813 | Prostate Cancer | soy isoflavones soy protein iso... placebo | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy | NCT00888654 | Prostate Cancer | B-Dim Radical Prosate... | 18 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel | NCT01469338 | Diarrhea Hormone-resista... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | cabazitaxel prednisone octreotide pamo... questionnaire a... octreotide acet... | 18 Years - | University of Southern California | |
| Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer | NCT00450749 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... | placebo therapeutic con... laboratory biom... lycopene | 18 Years - | National Cancer Institute (NCI) | |
| Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | NCT00984919 | Prostate Cancer | high performanc... laboratory biom... mass spectromet... | 40 Years - 120 Years | Barbara Ann Karmanos Cancer Institute | |
| Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | NCT00086736 | Prostate Cancer | bicalutamide eflornithine oral eflornithi... oral bicalutami... | 18 Years - | University of Alabama at Birmingham | |
| Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | NCT00989105 | Prostate Cancer | immunohistochem... laboratory biom... pharmacological... computed tomogr... magnetic resona... single photon e... technetium Tc 9... | 18 Years - | Cancer Research UK | |
| PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 | NCT01672905 | Prostate Cancer | laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| APC8015 and Bevacizumab in Treating Patients With Prostate Cancer | NCT00027599 | Prostate Cancer | bevacizumab prostatic acid ... sipuleucel-T therapeutic aut... in vitro-treate... | - | National Cancer Institute (NCI) | |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | NCT00771017 | Prostate Cancer | GVAX prostate c... bicalutamide goserelin leuprolide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer | NCT00049309 | Prostate Cancer | dietary interve... flaxseed | 18 Years - 120 Years | Duke University | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | NCT01656304 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | bevacizumab laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer | NCT01928485 | Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | active surveill... Sunphenon laboratory biom... Questionnaire A... | 45 Years - 85 Years | Case Comprehensive Cancer Center | |
| Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | NCT00003858 | Prostate Cancer | mitoxantrone hy... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | NCT01009736 | Prostate Cancer | tomato-soy juic... laboratory biom... pharmacological... therapeutic con... | - | Ohio State University Comprehensive Cancer Center | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone Therapy | NCT01656304 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | bevacizumab laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | NCT00433407 | Breast Cancer Lung Cancer Ovarian Cancer Prostate Cancer Sarcoma Unspecified Adu... | trastuzumab | - | Jonsson Comprehensive Cancer Center | |
| Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer | NCT00651326 | Prostate Cancer | bicalutamide buserelin flutamide goserelin leuprolide acet... neoadjuvant the... quality-of-life... radiation thera... Docetaxel | 18 Years - | Canadian Cancer Trials Group | |
| Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors | NCT03880422 | Cancer Survivor Obesity Overweight Prostate Adenoc... Stage A Prostat... Stage B Prostat... Stage C Prostat... Stage D Prostat... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | Dietary Interve... Educational Int... Exercise Interv... Quality-of-Life... Survey Administ... | 18 Years - | Roswell Park Cancer Institute | |
| Study of a Polymorphism in Patients With Prostate Cancer | NCT00900185 | Prostate Cancer | mutation analys... polymerase chai... polymorphism an... | - | National Cancer Institute (NCI) | |
| Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | NCT00771017 | Prostate Cancer | GVAX prostate c... bicalutamide goserelin leuprolide acet... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer | NCT02179762 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | moderate exerci... vigorous exerci... questionnaire a... laboratory biom... vigorous exerci... Exercise Logs Adherence Exercise and bo... | 18 Years - 75 Years | Case Comprehensive Cancer Center | |
| Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy | NCT01555632 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | atorvastatin ca... placebo | 19 Years - | University of Nebraska | |
| GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer | NCT00400517 | Prostate Cancer | sargramostim thalidomide conventional su... neoadjuvant the... | - 120 Years | The Cleveland Clinic | |
| GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer | NCT00305669 | Prostate Cancer | sargramostim immunohistochem... immunological d... laboratory biom... conventional su... neoadjuvant the... | - | University of California, San Francisco | |
| Lapatinib Ditosylate in Treating Patients With a Rising PSA Indicating Recurrent Prostate Cancer | NCT00103194 | Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Group Therapy Compared With Educational Materials in Patients With Prostate Cancer | NCT00002848 | Prostate Cancer Psychosocial Ef... | psychosocial as... quality-of-life... | - | University of Rochester | |
| Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | NCT00653757 | Prostate Cancer | goserelin aceta... leuprolide acet... image-guided ra... intensity-modul... | 19 Years - | Mayo Clinic | |
| Visually Enhanced Education About Prostate Cancer | NCT02846870 | Stage I Prostat... Stage II Prosta... Stage III Prost... | Visually enhanc... Standard prosta... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery | NCT00977457 | Prostate Cancer | DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | NCT00073970 | Prostate Cancer | celecoxib | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Brachytherapy in Treating Patients With Recurrent Prostate Cancer | NCT00005939 | Prostate Cancer | brachytherapy phosphorus P32 | 21 Years - | National Cancer Institute (NCI) | |
| Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer | NCT01859689 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... | brachytherapy image-guided ra... laboratory biom... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms | NCT00005073 | Prostate Cancer | zoledronic acid | 18 Years - | Novartis | |
| Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer | NCT00043069 | Osteoporosis Prostate Cancer | calcium carbona... cholecalciferol Estrogen Antago... risedronate sod... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | NCT01912820 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | green tea extra... quercetin placebo therapeutic con... laboratory biom... | 40 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer | NCT00002889 | Prostate Cancer | flutamide goserelin leuprolide acet... low-LET photon ... | 30 Years - | Alliance for Clinical Trials in Oncology | |
| Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | NCT00736645 | Prostate Cancer | selenomethionin... finasteride placebo | 18 Years - | Roswell Park Cancer Institute | |
| Genistein in Treating Patients With Prostate Cancer | NCT01126879 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage II Prosta... Stage III Prost... | genistein placebo therapeutic con... | 18 Years - | Northwestern University | |
| Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy | NCT00788307 | Prostate Cancer | Ad5-CMV-NIS liothyronine so... reverse transcr... laboratory biom... iodine I 131 | 18 Years - 120 Years | Mayo Clinic | |
| Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | NCT01535040 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Tobacco Use Dis... | memantine hydro... placebo | 18 Years - | Wake Forest University Health Sciences | |
| Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance | NCT01238172 | Prostate Cancer | dietary educati... prostate cancer... | 50 Years - 80 Years | Alliance for Clinical Trials in Oncology | |
| Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | NCT00243048 | Prostate Cancer | soy protein iso... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer | NCT00006365 | Prostate Cancer | brachytherapy iodine I 125 radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
| PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer | NCT00898326 | Prostate Cancer | biopsy | 20 Years - 75 Years | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | |
| Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer | NCT00589472 | Prostate Adenoc... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... | Bicalutamide Goserelin Aceta... Laboratory Biom... Leuprolide Acet... Therapeutic Con... Vorinostat | 19 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
